The Late-Breaking Clinical Trial session emphasizes the most recent and groundbreaking research in the field of neuromodulation.
Read more...This session is dedicated to spotlighting the work NANS is doing to advocate for you and your patients, how you can harness your neuromodulation practice, and strategies for keeping patients safe.
Read more...This session will highlight a number of presentations regarding remote care, social media and patient care, and the future of NANS educational certifications.
Read more...During this session, important topics in neuromodulation will be covered, including: Psychiatric Neuroengineering, FDA Approval Standards for PCLC Systems, and Fundamentals of Physiologic Closed-Loop Control Systems.
Read more...